arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

BillionToOne, Inc.

BLLN
$112.18 ▼ -1.35 (-1.19%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
11 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
57
Health
Fair
Bullish
auto_awesome

Analytical Summary

BillionToOne, Inc. shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $5.2B
Dividend Yield —
Revenue Growth 64.4% ↘
Op. Margin 5.0% ↘
ROIC 0.9% ↘
FCF / Share $0.11 ↘
Trailing P/E 659.9x
Price / Book 9.7x
FCF Yield 0.1%
Debt / Equity 0.17
info Valuation on last close. End-of-day price, Nov 5, 2026.

11-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$109.45M
↑ +64.4% —
Net Income Profit after all expenses
$8.05M
↓ -55.2% —
Operating Margin Operating profit as % of sales
5.0%
↓ -69.4% 43th
FCF / Share Free cash flow per share
$0.11
↓ -54.1% —
Long-Term Debt Long-term obligations
$91.03M
↑ +1.1% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
43
Returns ↓
47
Financial Health
74
Cash Quality ↑
87

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 4 years · 11 quarters